Synta Pharma (SNTA) Reports Q3 Loss of $0.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street mixed as oil prices surge, investors await earnings, economic data
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Total operating expenses: 14.09M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Total operating expenses: 14.09M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Synta Pharma (NASDAQ: SNTA) reported Q3 EPS of ($0.13), versus ($0.19) reported last year.
For earnings history and earnings-related data on Synta Pharma (SNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SolarMax Technology (SMXT) Misses Q2 EPS by 98c
- Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
- eBay named Morgan Stanley top pick on live commerce flywheel; stock surges
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
